DUB3 as a Cancer Therapy Target

MODULATION OF SURVIVIN EXPRESSION

siRNA targeting cyclin-dependent kinase 4 (CDK4)

Retrotransposon Inhibition in Therapy

Modulation of eIF4E-BP2 expression

Method of classifying antibody, method of identifying antigen, method of obtaining antibody or antibody set, method of constructing antibody panel and antibody or antibody set and use of the same

Small interfering RNAs targeting feline herpes virus

Glycoconjugates of RNA interference agents

Determinants of sensitivity to chemotherapeutic agents

Nucleic acid agents for downregulating H19, and methods of using same

Compositions and methods for RNA interference with sialidase expression and uses thereof

GENE THERAPY FOR CANCER USING SMALL INTERFERING RNA SPECIFIC TO ANT2 AND A METHOD TO OVERCOME TOLERANCE TO ANTITUMOR AGENT

Gene and polypeptide relating to breast cancer

Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA

AGENTS FOR IMPROVING INFLAMMATORY BOWEL DISEASE

si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation

Modified short interfering RNA

Functional nucleic acid ligands to fluorescent proteins

Methods and compositions for RNA interference

TAK1-D mediated induction of cell death in human cancer cells by specific sequence short double-stranded RNAS

USE OF COMPOUNDS THAT INTERFERE WITH THE HEDGEHOG SIGNALING PATHWAY FOR THE MANUFACTURE OF A MEDICAMENT FOR PREVENTING, INHIBITING, AND/OR REVERSING OCULAR DISEASES RELATED WITH OCULAR NEOVASCULARIZATION

Interfering RNA duplex having blunt-ends and 3′-modifications

RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA)

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

Multitargeting interfering RNAs having two active strands and methods for their design and use

miR-21 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION

siRNA targeting connective tissue growth factor (CTGF)

Compositions and methods for siRNA inhibition of HIF-1 alpha

Compositions, kits, and methods for the modulation of immune responses using galectin-1

Constitutively active fragments of eukaryotic heat shock RNA

Interfering RNA molecules

SiRNA DELIVERY INTO MAMMALIAN NERVE CELLS

RNA sequence-specific mediators of RNA interference

IDENTIFICATION OF JAK/STAT PATHWAY MODULATING GENES BY GENOME WIDE RNAI SCREENING

RNA SILENCING COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUNTINGTON'S DISEASE

Augmentation of endothelial thromboresistance

Transgenic plants modified for reduced cadmium transport, derivative products, and related methods

Small internally segmented interfering RNA

siRNA targeting phosphatases

Specific GRP78 expression-inhibition RNAi sequence, medicine thereof and method thereof

Methods and compositions for treating keratin hyperproliferative disorders

COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF HUMAN HERPESVIRUS (HHV)-6

Methods and compositions for treating cellular proliferative diseases

PRODUCT AND PROCESS TO REGULATE A GENE NETWORK INVOLVED IN CONSTITUTIVE INFLAMMATION AND EARLY CANCER PROGRESSION

DETECTION OF PKC-IOTA AS A BIOMARKER FOR BRAIN TUMORIGENESIS

Arginase II: a target for the prevention of atherosclerosis

Identification of a micro-RNA that activates expression of β-myosin heavy chain

METHOD OF TREATING NEURODEGENERATIVE DISEASE

Treatment of CNS conditions

DOUBLE-STRANDED RNA STRUCTURES AND CONSTRUCTS, AND METHODS FOR GENERATING AND USING THE SAME

Methods and compositions involving miRNA and miRNA inhibitor molecules

Complex for transferring an anionic substance into a cell

Composition Suppressing The Expression of Target Gene in Eyeball and Medicament For Treating of Disease in Eyeball

METHOD FOR DEMONSTRATING PRESENCE OR ABSENCE OF MARKERS ASSOCIATED WITH THE PRESENCE AND/OR THE CHEMOSENSITIVITY OF TUMORS

Use of fructose-based compounds for the diagnosis of cancer

Small interfering rnas that efficiently inhibit viral expression and methods of use thereof

Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases

Inhibitors of ribonucleotide reductase subunit 2 and uses thereof

Negative immunomodulation of immune responses by ERp5

Gene therapy and pharmaceutical composition for prevention and treatment of lung cancer

Modified gene-silencing RNA and uses thereof

siRNA targeting myeloid cell leukemia sequence 1

siRNA targeting tumor necrosis factor receptor superfamily member 1A

METHODS FOR DELIVERY OF NUCLEIC ACIDS

miR-200 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION

miR-20 Regulated Genes and Pathways as Targets for Therapeutic Intervention

Therapeutic Agent for Corneal Diseases

COMPOSITIONS AND METHODS FOR MODULATION OF PDX-1

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING BRAIN CANCER AND IDENTIFYING NEURAL STEM CELLS

Noxin, a novel stress-induced gene involved in cell cycle and apoptosis

Novel siRNAS and methods of use thereof

COMPOSITIONS COMPRISING HDAC INHIBITORS AND METHODS OF THEIR USE IN RESTORING STEM CELL FUNCTION AND PREVENTING HEART FAILURE

siRNA targeting hypoxia-inducible factor 1

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ASTHMA OR OTHER ALLERGIC OR INFLAMMATORY DISEASES

RNA INTERFERENCE MEDIATED INHIBITION OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

SNP BINDING SITE FOR microRNAs IN HLA-G

Use of inhibitors of scinderin and/or ephrin-A1 for treating tumors

RNAi inhibition of alpha-ENaC expression

RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)

Novel siRNAS and methods of use thereof

METHODS AND COMPOSITIONS FOR MODULATING FOXO1 ACTIVITY AND INSULIN SIGNALING

GPR17 modulators, method of screening and uses thereof

Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA

METHOD OF INHIBITING EXPRESSION OF TARGET MRNA USING SIRNA CONSISTING OF NUCLEOTIDE SEQUENCE COMPLEMENTARY TO SAID TARGET MRNA

DKKL-1 splice product modulators for cancer diagnosis and therapy

Polypeptide compounds for inhibiting angiogenesis and tumor growth

Method for retarding the differentiation of pluripotent cells

RNA Interference Mediating Small RNA Molecules

SiRNA targeting KRAS

RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

SiRNA silencing of genes expressed in cancer

Composition comprising double stranded RNA that inhibits expression of NEU3 and method for treating cancer

Methods for regulation of p53 translation and function

Cell-type specific aptamer-siRNA delivery system for HIV-1 Therapy

Application of RNA Interference Targeting DHFR Gene, to Cell for Protein Production

METHOD FOR TREATING CANCER USING INTERFERENCE RNA

ATF4 As A Therapeutic Target In Alzheimers Disease And Other Neurological Disorders

Modular polynucleotides for ligand-controlled regulatory systems

MicroRNAs

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

Compositions and methods for inhibiting expression of a gene from the Ebola

Cell transfecting formulations of small interfering RNA related compositions and methods of making and use

Nucleic acid agents for downregulating H19 and methods of using same

Breast cancer related gene ZNFN3A1

MANIPULATING SP1 ACTIVITY TO IMPROVE THERAPEUTIC CLONING

Pancreatic cancer targets and uses thereof

SENSITIZING A CELL TO CANCER TREATMENT BY MODULATING THE ACTIVITY OF A NUCLEIC ACID ENCODING RPS27L PROTEIN

Methods and compositions for silencing genes without inducing toxicity

RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (SINA)

RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/ REL-A GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF ANGIOPOIETIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same

MICRORNA TARGET SITE BLOCKING OLIGOS AND USES THEREOF

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)

Splicing-Mediated Regulation Of Gene Expression

TARGETING OPPOSITE STRAND REPLICATION INTERMEDIATES OF SINGLE-STRANDED VIRUSES BY RNAI

Interfering RNAs targeting the morbillivirus nucleoprotein gene

Conserved Membrane Activator of Calcineurin (CMAC), a Novel Therapeutic Protein and Target

Inducible SIRNA expression cassette and method of use

Tripartite RNAi constructs

LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY

MULTICISTRONIC VECTORS AND METHODS FOR THEIR DESIGN

Methods and Compositions for Modulating Body Weight and for Treating Weight Disorders and Related Diseases

MICRORNAS DIFFERENTIALLY EXPRESSED IN PANCREATIC DISEASES AND USES THEREOF

Treatment for allograft rejection

Reduction of off-target RNA interference toxicity

PROSTATE CARCINOGENESIS PREDICTOR

Rna constructs

Influenza Therapeutic

Antisense modulation of PTP1B expression

OLIGONUCLEIC ACID-BEARING COMPOSITE AND PHARMACEUTICAL COMPOSITION CONTAINING THE COMPOSITE

INHIBITION OF THE SH2-DOMAIN CONTAINING PROTEIN TYR-PHOSPHATASE, SHP-1, TO ENHANCE VACCINES

Compositions for Bacterial Mediated Gene Silencing and Methods of Using the Same

CCR3 inhibition for ocular angiogenesis and macular degeneration

siRNA targeting nucleoporin 62kDa (Nup62)

Compositions for conferring tolerance to viral disease in social insects, and the use thereof

RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF APO-B100 EXPRESSION

Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases

Use of apoptosis-specific eIF-5A siRNA to down regulate expression of proinflammatory cytokines to treat sepsis

RNA interference for the treatment of gain-of-function disorders

siDNA against Influenza Virus

Targeting ABCB5 for cancer therapy

Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases

PAR-4 RELATED METHODS AND COMPOSITIONS

Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity

Influenza Therapeutic

RNAi-MEDIATED INHIBITION OF STROMAL CELL-DERIVED FACTOR 1-RELATED TARGETS FOR TREATMENT OF NEOVASCULARIZATION-RELATED CONDITIONS

RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

ALLELE-SPECIFIC SILENCING OF DISEASE GENES

Compositions and methods for siRNA inhibition of ICAM-1

COMPOSITIONS AND METHODS FOR SIRNA INHIBITION OF ANGIOGENESIS

SEMA4D in cancer diagnosis, detection and treatment

EML4-ALK fusion gene

SHORT INTERFERING RNA AS AN ANTIVIRAL AGENT FOR HEPATITIS C

RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF MYOSTATIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

Methods and compositions for the treatment of eye disorders with increased intraocular pressure

Interfering RNAs against the promoter region of P53

Nogo receptor antagonists

Construction of pool of interfering nucleic acids covering entire RNA target sequence and related compositions

Reagents and Methods for miRNA Expression Analysis and Identification of Cancer Biomarkers

Methods and compositions for controlling efficacy of RNA silencing

Technology for the Preparation of Microparticles

PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease

Treatment of neurodegenerative diseases by the use of scd4 inhibitors

Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives

RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acid (siNA)

USE OF EIF-5A1 SIRNA TO PROTECT ISLETS CELLS FROM APOPTOSIS AND TO PRESERVE THEIR FUNCTIONALITY

Tumor inhibition by modulating sprouty expression of activity

RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)

RNAi modulation of SCAP and therapeutics uses thereof

Transducible delivery of siRNA by dsRNA binding domain fusions to PTD/CPPS

Enhanced retinal delivery of a nucleic acid through iontophoresis

siRNA targeting transducin (beta)-like 3 (TBL3)

Primer-extension based method for the generation of siRNA/miRNA expression vectors

NFIA in glial fate determination, glioma therapy and astrocytoma treatment

METHODS OF TREATING BONE DISORDERS WITH MODULATORS OF AXL

siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)

DRUG FOR PREVENTING AND TREATING ATHEROSCLEROSIS

Methods for producing microRNAs

Diagnosis, prevention and treatment of cancer

Methods of treatment of acute renal failure

Polynucleotide for Target Gene

Pharmaceutical composition for treating cancer

Double-stranded RNA oligonucleotides which inhibit tyrosinase expression

Methods for identifying compounds for the treatment of type 1 diabetes

Inhibitors of Ste20-like Kinase (SLK) and Methods of Modulating Cell Cycle Progression and Cell Motility

INHIBITING DNA POLYMERASE BETA TO ENHANCE EFFICACY OF ANTICANCER AGENTS

GENE SILENCING BY SYSTEMIC RNA INTERFERENCE

IG20 splice variants therapeutics for cancer

METHODS OF INHIBITING TUMOR CELL PROLIFERATION WITH FOXM1 siRNA

Compositions and methods for treatment of colorectal cancer

Method of treatment using a cytokine able to bind IL-18BP to inhibit the activity of a second cytokine

METHODS AND COMPOSITIONS FOR NUCLEIC ACID TRANSFER INTO CELLS

siRNA targeting inner centromere protein antigens (INCENP)

CATIONIC ALPHA-AMINO ACID-CONTAINING BIODEGRADABLE POLYMER GENE TRANSFER COMPOSITIONS

CREATING POULTRY AND OTHER ANIMALS RESISTANT TO VIRAL DISEASE

METHOD AND COMPOSITION FOR REDUCING THE EXPRESSION OF ROCK-II

piRNA and uses related thereto

Method and compositions for inhibiting MAGE protein interaction with KAP-1

Compositions and methods for inhibiting expression of a gene from the JC virus

Compositions and methods of treating cancer

Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases

Methods for the identification of microRNA and their applications in research and human health

siRNA and methods of manufacture

Methods for Identifying Compounds for the Treatment of Type 1 Diabetes

Devices, systems and methods for improving memory and/or cognitive function through brain delivery of siRNA

Ii-RNAi involved Ii suppression in cancer immunotherapy

RNAi MEDIATED KNOCKDOWN OF NUMA FOR CANCER THERAPY

RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF OCULAR NEOVASCULARIZATION

Peripherin and Neurofilament Light Protein Splice Variants in Amyotrophic Lateral Sclerosis (ALS)

NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs

Compositions and methods for inhibiting car gene expression by RNA interference

MODULATION OF SYNAPTOGENESIS

Chn-1/Chip-Antagonists For The Treatment Of Muscular Diseases

ANTI-VIRAL COMPOSITIONS AND METHODS OF USE IN CATTLE

Oligonucleotide modulation of cell adhesion

Membrane receptor for retinol binding protein mediates cellular uptake of vitamin A, methods of use and compositions

COMPOSITIONS AND METHODS OF SPHINGOSINE KINASE INHIBITORS FOR USE THEREOF IN CANCER THERAPY

Telomerase RNA Subunit and Methods of Use Thereof

Method to Treat Flavivirus Infection with siRNA

Pharmaceutical composition for obstructive vascular disease

Inhibitors of prolyl-hydroxylase-1 for the treatment of skeletal muscle degeneration

Prophylactic/Therapeutic Agent for Cancer

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

siRNA targeting minichromosome maintenance deficient 3 (MCM3)

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

Nucleic Acid-Lipopolymer Compositions

Methods and compositions for treating gain-of-function disorders using RNA interference

Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer

Methods and kits for linking polymorphic sequences to expanded repeat mutations

Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells

INTRACELLULAR EXPRESSION AND DELIVERY OF siRNAs IN MAMMALIAN CELLS

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA

RNAi-RELATED INHIBITION OF TNFalpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS

RNA INTERFERENCE SUPPRESSION OF NEURODEGENERATIVE DISEASES AND METHODS OF USE THEREOF

Angiogenesis Affecting Polypeptides, Proteins, and Composition, and Methods of Use Thereof

RNAi Medicine Having No Adverse Effects

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA

siRNA targeting 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2)

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

RNA interference in respiratory epithelial cells

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

Method on clinical applications in head neck cancer by using DSG3 molecule for predicting malignant degree of cancer, serving as a molecular target and using RNA jamming sequence on inhibition-specific of DSG3 expression

Use of GILZ protein expressed in dendritic cells to modulate an antigen-specific immune response

MARKERS FOR DIAGNOSIS OF CANCER AND ITS USE

Emmprin antagonists and uses thereof

Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes

Compositions and methods for studying and treating inflammatory diseases and disorders

SHRNA AND SIRNA AND MIRNA EXPRESSION IN A LIVING ORGANISM UNDER CONTROL OF A CODON-OPTIMIZED REPRESSOR GENE

siRNA targeting ribosomal protein S2 (RPS2)

siRNA targeting kinesin spindle protein (KSP)

RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Rnai Agents for Maintenance of Stem Cells

Regulation of Transgene Expression by RNA Interference

Double-Stranded Oligonucleotides

Crosslinking agent, crosslinking method, method of controlling gene expression, and method of examining gene function

siRNA microbicides for preventing and treating diseases

Trefoil Factors and Methods of Treating Proliferation Disorders Using Same

Orthotopic, controllable, and genetically tractable non-human animal model for cancer

Methods of enhancing long term memory formation by inhibition of Gpr12

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

MODIFICATION OF DOUBLE-STRANDED RIBONUCLEIC ACID MOLECULES

INHIBITION OF BRAIN ENZYMES INVOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION

Method for maintaining pluripotency of stem/progenitor cells

SP35 antibodies and uses thereof

Compositions and methods for the treatment of respiratory disorders

System and method for identification of microRNA target sites and corresponding targeting microRNA sequences

RNAi-MEDIATED INHIBITIN OF HTRA1 FOR TREATMENT OF MACULAR DEGENERATION

Hybrid interfering RNA

Delivery of siRNA by neutral lipid compositions

Short Interfering Rna and Micro-Rna Compounds and Methods of Designing, Making, and Using the Same

Composition for Suppressing Expression of Target Gene

ANTI-TUMOR VACCINES DELIVERED BY DENDRITIC CELLS DEVOID OF INTERLEUKIN-10

TREATMENT OF CANCER WITH ANTI-MUSCARINIC RECEPTOR AGENTS

Use of cytochrome P450 reductase as insecticidal target